Literature DB >> 17982648

Analysis of CXCL12 3'UTR G>A polymorphism in colorectal cancer.

M Hidalgo-Pascual1, J J Galan, M Chaves-Conde, J A Ramírez-Armengol, C Moreno, E Calvo, P Pelaez, C Crespo, A Ruiz, J L Royo.   

Abstract

Colorectal cancer is one of the most prevalent cancers in developed countries. However, the genetic factors influencing its appearance remain far from being fully characterized. Recently, a G>A functional transition mapping the 3' untranslated region of the CXCL12 gene (rs1801157) has been found to be under-represented among rectal cancer patients when compared to colon cancer patients from a Swedish series. Here we present the results from an independent analysis of CXCL12 rs1801157 in a larger CRC series of Spanish origin in order to analyse the robustness of this association within a different European population. No significant difference was observed between controls and colon or rectal cancer patients. We were also unable to find a correlation between rs1801157 and different prognostic markers such as metastasis development or disease-free survival time. The epidemiologic data involving CXCL12 rs1801157 in colorectal cancer risk are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982648     DOI: 10.3892/or.18.6.1583

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.

Authors:  Dan Meng; Yin-Xiang Wu; Vidhi Heerah; Shuang Peng; Meng-di Chu; Yong-Jian Xu; Wei-Ning Xiong; Shu-Yun Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

Authors:  Ferruh K Işman; Canan Kucukgergin; Selçuk Daşdemir; Bedia Cakmakoglu; Oner Sanli; Sule Seckin
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

3.  CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population.

Authors:  Weijia Liu; Enxin Zhu; Ru Wang; Lihong Wang; Tingjiao Liu
Journal:  Med Oncol       Date:  2011-02-05       Impact factor: 3.064

4.  SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers.

Authors:  Mahboobeh Razmkhah; Abbas Ghaderi
Journal:  Indian J Gastroenterol       Date:  2012-12-16

5.  Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Authors:  S N Maley; S M Schwartz; L G Johnson; M Malkki; Q Du; J R Daling; S S Li; L P Zhao; E W Petersdorf; M M Madeleine
Journal:  Int J Immunogenet       Date:  2009-09-24       Impact factor: 1.466

6.  Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues.

Authors:  Risala Hussain Allami; Claudine Graf; Ksenia Martchenko; Beatrice Voss; Marc Becker; Martin R Berger; Peter R Galle; Matthias Theobald; Thomas C Wehler; Carl C Schimanski
Journal:  Oncol Lett       Date:  2016-01-25       Impact factor: 2.967

7.  CXCL12-G801A polymorphism modulates risk of colorectal cancer in Taiwan.

Authors:  Ming-Der Shi; Jing-Hsien Chen; Hsin-Te Sung; Jung-Shin Lee; Li-Yu Tsai; Hui-Hsuan Lin
Journal:  Arch Med Sci       Date:  2013-11-29       Impact factor: 3.318

8.  Examining the polymorphisms in the hypoxia pathway genes in relation to outcome in colorectal cancer.

Authors:  Asan M S Haja Mohideen; Angela Hyde; Jessica Squires; Jing Wang; Elizabeth Dicks; Ban Younghusband; Patrick Parfrey; Roger Green; Sevtap Savas
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

9.  The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.

Authors:  Ke Zhu; Benchun Jiang; Rong Hu; Ying Yang; Miao Miao; Yingchun Li; Zhuogang Liu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

10.  The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants.

Authors:  Xiang Tong; Yao Ma; Huajiang Deng; Xixi Wang; Sitong Liu; Zhipeng Yan; Shifeng Peng; Hong Fan
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.